Viewing Study NCT04758806



Ignite Creation Date: 2024-05-06 @ 3:46 PM
Last Modification Date: 2024-10-26 @ 1:57 PM
Study NCT ID: NCT04758806
Status: UNKNOWN
Last Update Posted: 2022-08-03
First Post: 2021-01-21

Brief Title: Fecal Microbial Transplantation in Severe Alcoholic Hepatitis
Sponsor: FD Roosevelt Teaching Hospital with Policlinic Banska Bystrica
Organization: FD Roosevelt Teaching Hospital with Policlinic Banska Bystrica

Study Overview

Official Title: Fecal Microbial Transplantation for Corticosteroids Non-responders and Non-eligible Patients With Severe Alcoholic Hepatitis
Status: UNKNOWN
Status Verified Date: 2022-08
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: FMTH7
Brief Summary: 1 A subtype of Alcoholic hepatitis AH named severe alcoholic hepatitis SAH is associated with high short-term mortality J Hepatol 2019
2 The only SAH treatment option - corticosteroids CS - are often contraindicated or ineffective STOPAH Trial
3 New treatment modalities for remaining patients are much needed
4 Fecal microbial transplantation FMT is one of the promising therapies
5 Investigators aimed to see if FMT improves survival in patients admitted with SAH not responding to- or non-eligible for CS
Detailed Description: FMT via upper GI tract is provided to CS non-responders NR or non-eligible NE adult patients hospitalized with SAH determined by the Lille-model
Modified version of the Sarin FMT protocol is used with microbiota material procured from unrelated healthy donors

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None